Needham Reiterates Hold on Gilead Sciences
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Joseph Stringer has reiterated a Hold rating on Gilead Sciences (NASDAQ:GILD).
August 15, 2024 | 11:34 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Needham analyst Joseph Stringer has reiterated a Hold rating on Gilead Sciences.
The reiteration of a Hold rating suggests that the analyst does not see significant upside or downside potential in the short term. This is likely to result in a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100